| __timestamp | Cytokinetics, Incorporated | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 72471000 |
| Thursday, January 1, 2015 | 19667000 | 89204000 |
| Friday, January 1, 2016 | 27823000 | 106010000 |
| Sunday, January 1, 2017 | 36468000 | 137905000 |
| Monday, January 1, 2018 | 31282000 | 159888000 |
| Tuesday, January 1, 2019 | 39610000 | 158425000 |
| Wednesday, January 1, 2020 | 52820000 | 200677000 |
| Friday, January 1, 2021 | 96803000 | 304759000 |
| Saturday, January 1, 2022 | 177977000 | 377221000 |
| Sunday, January 1, 2023 | 173612000 | 336361000 |
Unleashing insights
In the competitive landscape of biotechnology and pharmaceuticals, managing operational costs is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Supernus consistently outpaced Cytokinetics in SG&A spending, with an average annual expense nearly three times higher. Notably, in 2022, Supernus's SG&A expenses peaked at approximately 378 million, marking a 400% increase from 2014. Meanwhile, Cytokinetics saw a significant rise in 2022, with expenses reaching around 178 million, a tenfold increase from 2014. This trend highlights the aggressive expansion and operational scaling within these companies. Understanding these financial dynamics offers valuable insights into their strategic priorities and market positioning.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Supernus Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Biogen Inc. or Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Cytokinetics, Incorporated
Who Optimizes SG&A Costs Better? Insmed Incorporated or Supernus Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Catalent, Inc. vs Cytokinetics, Incorporated
Operational Costs Compared: SG&A Analysis of Cytokinetics, Incorporated and Soleno Therapeutics, Inc.
Analyzing Cost of Revenue: Cytokinetics, Incorporated and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and Geron Corporation
Cytokinetics, Incorporated or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Ionis Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Verona Pharma plc or Supernus Pharmaceuticals, Inc.